Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 283

1.

Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.

Pfeiffer D, Berger J, Gross AJ.

BJU Int. 2012 Dec;110(11):1702-7. doi: 10.1111/j.1464-410X.2012.11375.x. Epub 2012 Aug 29.

PMID:
22928703
[PubMed - indexed for MEDLINE]
2.

Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology.

Pinthus JH, Farrokhyar F, Hassouna MM, Woods E, Whelan K, Shayegan B, Orovan WL.

BJU Int. 2012 Oct;110(8):1142-8. doi: 10.1111/j.1464-410X.2012.10945.x. Epub 2012 Feb 28.

PMID:
22372721
[PubMed - indexed for MEDLINE]
3.

Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.

Thüroff S, Chaussy C.

J Urol. 2013 Aug;190(2):702-10. doi: 10.1016/j.juro.2013.02.010. Epub 2013 Feb 13.

PMID:
23415962
[PubMed - indexed for MEDLINE]
4.

HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.

Asimakopoulos AD, Miano R, Virgili G, Vespasiani G, Finazzi Agrò E.

Urol Oncol. 2012 Sep;30(5):577-83. doi: 10.1016/j.urolonc.2010.08.019. Epub 2011 Feb 2.

PMID:
21292508
[PubMed - indexed for MEDLINE]
5.

Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.

Crouzet S, Chapelon JY, Rouvière O, Mege-Lechevallier F, Colombel M, Tonoli-Catez H, Martin X, Gelet A.

Eur Urol. 2014 May;65(5):907-14. doi: 10.1016/j.eururo.2013.04.039. Epub 2013 Apr 30.

PMID:
23669165
[PubMed - indexed for MEDLINE]
6.

Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer.

Ganzer R, Fritsche HM, Brandtner A, Bründl J, Koch D, Wieland WF, Blana A.

BJU Int. 2013 Aug;112(3):322-9. doi: 10.1111/j.1464-410X.2012.11715.x. Epub 2013 Jan 28.

PMID:
23356910
[PubMed - indexed for MEDLINE]
7.

Experience with high-intensity focused ultrasound therapy for management of organ-confined prostate cancer: critical evaluation of oncologic outcomes.

Komura K, Inamoto T, Masuda H, Watsuji T, Azuma H.

Acta Biomed. 2012 Dec;83(3):189-96.

PMID:
23762994
[PubMed - indexed for MEDLINE]
8.

High-intensity focused ultrasound therapy for clinically localized prostate cancer.

Lee HM, Hong JH, Choi HY.

Prostate Cancer Prostatic Dis. 2006;9(4):439-43. Epub 2006 Jul 18.

PMID:
16847468
[PubMed - indexed for MEDLINE]
9.

Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer.

Misraï V, Rouprêt M, Chartier-Kastler E, Comperat E, Renard-Penna R, Haertig A, Bitker MO, Richard F, Conort P.

World J Urol. 2008 Oct;26(5):481-5. doi: 10.1007/s00345-008-0286-8. Epub 2008 Jun 26.

PMID:
18581118
[PubMed - indexed for MEDLINE]
10.

PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.

Ganzer R, Rogenhofer S, Walter B, Lunz JC, Schostak M, Wieland WF, Blana A.

Eur Urol. 2008 Mar;53(3):547-53. Epub 2007 Jul 17.

PMID:
17662520
[PubMed - indexed for MEDLINE]
11.

Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer.

Blana A, Rogenhofer S, Ganzer R, Lunz JC, Schostak M, Wieland WF, Walter B.

Urology. 2008 Dec;72(6):1329-33; discussion 1333-4. doi: 10.1016/j.urology.2008.06.062. Epub 2008 Oct 1.

PMID:
18829078
[PubMed - indexed for MEDLINE]
12.

High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.

Challacombe BJ, Murphy DG, Zakri R, Cahill DJ.

BJU Int. 2009 Jul;104(2):200-4. doi: 10.1111/j.1464-410X.2009.08355.x. Epub 2009 Feb 11.

PMID:
19220245
[PubMed - indexed for MEDLINE]
13.

Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.

Murat FJ, Poissonnier L, Rabilloud M, Belot A, Bouvier R, Rouviere O, Chapelon JY, Gelet A.

Eur Urol. 2009 Mar;55(3):640-7. doi: 10.1016/j.eururo.2008.04.091. Epub 2008 May 9.

PMID:
18508188
[PubMed - indexed for MEDLINE]
14.

Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer.

Boutier R, Girouin N, Cheikh AB, Belot A, Rabilloud M, Gelet A, Chapelon JY, Rouvière O.

BJU Int. 2011 Dec;108(11):1776-81. doi: 10.1111/j.1464-410X.2011.10251.x. Epub 2011 Jun 28.

PMID:
21711432
[PubMed - indexed for MEDLINE]
15.

Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.

Inoue Y, Goto K, Hayashi T, Hayashi M.

Int J Urol. 2011 May;18(5):358-62. doi: 10.1111/j.1442-2042.2011.02739.x. Epub 2011 Mar 30.

PMID:
21449970
[PubMed - indexed for MEDLINE]
16.

Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry.

Blana A, Robertson CN, Brown SC, Chaussy C, Crouzet S, Gelet A, Conti GN, Ganzer R, Pasticier G, Thuroff S, Ward JF.

Prostate Cancer Prostatic Dis. 2012 Sep;15(3):256-9.

PMID:
22487909
[PubMed - indexed for MEDLINE]
17.

Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry.

Ganzer R, Robertson CN, Ward JF, Brown SC, Conti GN, Murat FJ, Pasticier G, Rebillard X, Thuroff S, Wieland WF, Blana A.

BJU Int. 2011 Oct;108(8 Pt 2):E196-201. doi: 10.1111/j.1464-410X.2011.10091.x. Epub 2011 Feb 18.

PMID:
21332907
[PubMed - indexed for MEDLINE]
18.

High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.

Blana A, Walter B, Rogenhofer S, Wieland WF.

Urology. 2004 Feb;63(2):297-300. Review.

PMID:
14972475
[PubMed - indexed for MEDLINE]
19.

High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.

Blana A, Brown SC, Chaussy C, Conti GN, Eastham JA, Ganzer R, Murat FJ, Pasticier G, Rebillard X, Rewcastle JC, Robertson CN, Thuroff S, Ward JF.

BJU Int. 2009 Oct;104(8):1058-62. doi: 10.1111/j.1464-410X.2009.08518.x. Epub 2009 Apr 17.

PMID:
19388986
[PubMed - indexed for MEDLINE]
20.

Treatment of localized prostate cancer using high-intensity focused ultrasound.

Uchida T, Ohkusa H, Nagata Y, Hyodo T, Satoh T, Irie A.

BJU Int. 2006 Jan;97(1):56-61.

PMID:
16336329
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk